Valeant Pharmaceuticals Options Traders Brace for Bigger Losses

VRX has struggled this year, and breached the key $18 level in February

Apr 6, 2018 at 9:54 AM
facebook X logo linkedin

Mizuho upgraded Valeant Pharmaceuticals Intl Inc (NYSE:VRX) to "neutral" from "underperform," and boosted its price target by $5 to $15. The brokerage firm said it doesn't see any "near term sell catalysts," and that it believes the Bausch + Lomb parent will reach its 2018 guidance. The analyst in coverage did caution, however, that it expects the drugmaker's turnaround efforts to take longer than forecast, and that growth will likely not be achieved until at least 2020.

Looking at the charts, it's been a rough year for VRX stock, which is down more than 35% from its early January annual high of $24.43. More recently, a handful of bear gaps in late February and early March sent the shares gapping below the key $18 level, which has served as support and resistance going back to 2016. At last check, VRX stock was up 0.3% at $15.81, but a number of options traders are betting on the equity to resume its longer-term slide.

At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 10-day put/call volume ratio of 1.36 ranks in the 100th annual percentile. In other words, puts have been bought to open over calls at a faster-than-usual clip.

The bulk of this action has centered at the April 14 put, where more than 6,900 positions were added in the past two weeks. Data from the major options exchanges confirms significant buy-to-open activity here, meaning traders expect VRX stock to breach $14 for the first time since an early November bear gap by the close on Friday, April 20 -- when the front-month options expire.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI